In theory, dose optimization is a relatively simple concept—make sure a drug’s dose delivers the best balance between risk and benefit for the patient—yet in practice it is a different story.
With new regulatory deadlines looming in the EU, it became clear that there would not be sufficient capacity to maintain existing medical devices and IVDs on the market and bring new ones to the public without a change of plans.
Offering up a variety of perspectives on ways to improve, broaden, and deepen the business aspects of the clinical research enterprise for the benefit of all its stakeholders.
Disruption and innovation are key to driving needed improvements in the clinical trial ecosystem. Sparks of inspiration are an essential step in this process.
The Association of Clinical Research Professionals (ACRP) today recognizes nearly 1,700 clinical research professionals who have demonstrated a long-term commitment to conducting clinical trials safely, ethically, and to the highest […]